Drug Design, Development and Therapy, 2018 Luping Wang,1 Canwei Zhang,2 Rui Hua3 1Department of Ophthalmology, University of Bonn, Bonn, Germany; 2Department of Ophthalmology, Weifang Eye Hospital, Weifang, People’s Republic of China; 3Department of Ophthalmology, First Hospital of China ...
Wang LP, Zhang CW, Hua R
doaj
Quantitative data analysis of optical coherence tomography angiography of different morphologies of macular neovascularization after intravitreal conbercept versus ranibizumab for neovascular age-related macular degeneration [PDF]
, 2022 Jing Li +5 more
openalex +1 more source
Short-Term Results of Switch from Conbercept to Bevacizumab or Ranibizumab in Eyes with Persistent Neovascular Age-Related Macular Degeneration [PDF]
, 2020 Zongyi Wang +7 more
openalex +1 more source
Drug Design, Development and Therapy, 2018 Yuting Peng, Xiongze Zhang, Miaoling Li, Bing Liu, Lan Mi, Chengguo Zuo, Feng Wen State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China Introduction: To evaluate the functional and morphological ...
Peng Y +6 more
doaj
Comparison of the Efficacy of Three Loading Doses of Intravitreal Injection of Conbercept with Injection Combined with PDT for the Treatment of PCV [PDF]
, 2020 Fengjiao Li, Aihua Ma, Bojun Zhao
openalex +1 more source
Retracted: Prognostic Factor Study of Macular Edema Recurrence in Retinal Vein Occlusion after Conbercept Treatment: A Post Hoc Analysis of the FALCON Study [PDF]
, 2023 Computational and Mathematical Methods in Medicine
openalex +1 more source
Visual function and visual quality in diabetic macular edema treated by Conbercept
, 2022 Peng Li +5 more
openalex +2 more sources